The pharmaceutical company Pfizer is helping to create a new company dedicated to the development of adult stem cell therapies for diabetes-induced retinal damage.
Researchers discover stem cell precursors of cardiomyocytes located in the outer layer of heart tissue.
As crippled horses, dogs and cats show dramatic improvement after being treated with adult stem cell therapy, their progress parallels similar advancements for humans.
Scientists at UC-Davis Children’s Hospital are the first to identify stem cells in the adult human bladder.
With newer, improved techniques for the administration of adult stem cells, an already viable therapy is made even more effective in the treatment of devastating spinal cord injuries.
Plans for the first clinical trial in the U.S. ever to be conducted with embryonic stem cells have now been postponed by the FDA.
